Search Results 841-850 of 3714 for 2024sweden

  1. Brugada syndrome - Doctors and departments - Mayo Clinic

    Learn about the symptoms, causes and treatments for this heart rhythm condition that is sometimes inherited.

  2. Testing The Use Of Ado-Trastuzumab Emtansine Compared To The Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) For Recurrent, Metastatic, Or Unresectable HER2-Positive Salivary Gland Cancer - Mayo Clinic

    The purpose of this study is to test whether ado-trastuzumab emtansine works to shrink tumors in patients with HER2-positive salivary gland cancer that has come ...

  3. Medical Research & Education - Mayo Clinic News Network

    New drug may reduce need for aortic valve surgeries by slowing disease progression featured image · VIDEO: Researchers find caregiving worsens menopause symptoms ...

  4. A Phase 3, Placebo-Controlled Study To Investigate LP352 In Children And Adults With Dravet Syndrome (DS) - Mayo Clinic

    The study consists of 3 main phases: Screening, Titration period, and Maintenance period, followed by a Taper period and Follow-Up. Participants will be ...

  5. Medical Research & Education - Mayo Clinic News Network

    Blood test shows promise for detecting testicular cancer when standard markers miss featured image · Mayo Clinic study finds bariatric surgery associated with ...

  6. A Study to Evaluate the Effectiveness and Safety of PRV-015 in Adult Patients wth Non-responsive Celiac Disease as an Adjunct to a Gluten-free Diet - Mayo Clinic

    A Study to Evaluate the Effectiveness and Safety of PRV-015 in Adult Patients wth Non-responsive Celiac Disease as an Adjunct to a Gluten-free Diet.

  7. A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) - Mayo Clinic

    Eligibility last updated 5/1/2024. Questions regarding updates should be directed to the study team contact. Participating Mayo Clinic locations. Study ...

  8. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma - Mayo Clinic

    Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment- ...

  9. News Releases

    2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016 · 2015 · 2014 · 2013 · 2012 · 2011 · Aging ...

  10. A Trial to Evaluate the Safety of GEN1046 in Patients with Malignant Solid Tumors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...